NCT01112462View on ClinicalTrials.gov

To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Respiratory Tract Infections
Interventions
DRUG

Paracetamol 500 mg/Phenylephrine 5 mg tablets

2 tablets to be administered orally with 240 ml of water with a 24 hour follow-up period

DRUG

Paracetamol 1000 mg/Phenylephrine 10 mg sachet

1 sachet dissolved in 240 ml water and administered orally with a 24 hour follow-up period

Trial Locations (1)

Unknown

Shandon Clinical Trials Ltd., Cork

Sponsors

Lead Sponsor

McNeil AB
All Listed Sponsors
lead

McNeil AB

INDUSTRY